我们自1999年3月～2000年4月,采用胆维他治疗抗痨药所致肝损害32例,并与对照组进行比较,结果如下。 1 临床资料 本组54例肺结核患者均为门诊、住院确诊的病人,按世界卫生组织规定短程化疗方案抗痨治疗。化疗最短1周,最长2个半月,患者有不同程度的乏力、纳差、厌油、恶心、腹胀、尿黄、皮肤巩膜黄染,肝功能异常。将病人随机分为治疗组和对照组。治疗组32例,男22例,女10例;年龄21～57岁,平均40.1±7.1岁。对照组22例,男15例,女7例;年龄20～59岁,平均39.7±6.2岁。两组患者在性别、年龄、病程、化 We from March 1999 to April 2000, the gallbladder Hepatitis B virus treatment of liver damage caused by 32 cases, and compared with the control group, the results are as follows. 1 Clinical data The group of 54 cases of tuberculosis patients are out-patient, hospitalized patients, according to the World Health Organization short-range chemotherapy regimen anti-tuberculosis treatment. The shortest one week chemotherapy, up to 2 and a half months, patients with varying degrees of fatigue, anorexia, tired of oil, nausea, abdominal distension, urinary yellow, skin scleral yellow dye, liver dysfunction. The patients were randomly divided into treatment group and control group. The treatment group of 32 patients, 22 males and 10 females; aged 21 to 57 years, mean 40.1 ± 7.1 years. Control group, 22 cases, 15 males and 7 females; aged 20 to 59 years, mean 39.7 ± 6.2 years. Two groups of patients in gender, age, duration of disease